Peter Canning

2.1k total citations · 1 hit paper
21 papers, 1.6k citations indexed

About

Peter Canning is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Peter Canning has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Peter Canning's work include HER2/EGFR in Cancer Research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Peter Canning is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Peter Canning collaborates with scholars based in United Kingdom, United States and Germany. Peter Canning's co-authors include Alex N. Bullock, F.J. Sorrell, Rumen V. Kostov, Albena T. Dinkova‐Kostova, F. von Delft, Sam W. Lee, Li Tan, Nathanael S. Gray, Stefan Knapp and A. Chaikuad and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Peter Canning

19 papers receiving 1.6k citations

Hit Papers

Structural basis of Keap1 interactions with Nrf2 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Canning United Kingdom 14 1.2k 258 145 144 129 21 1.6k
Ok‐Sun Bang South Korea 25 1.1k 0.9× 208 0.8× 169 1.2× 103 0.7× 82 0.6× 71 1.9k
Eugenia M. Yazlovitskaya United States 25 1.2k 1.0× 423 1.6× 166 1.1× 120 0.8× 59 0.5× 48 1.9k
Susumu Tanimura Japan 25 1.2k 1.0× 283 1.1× 253 1.7× 172 1.2× 110 0.9× 46 1.8k
ShouWei Han United States 20 1.1k 0.9× 266 1.0× 84 0.6× 167 1.2× 143 1.1× 30 1.6k
Richard M. Niles United States 24 1.2k 1.0× 209 0.8× 246 1.7× 177 1.2× 73 0.6× 64 1.8k
Daisuke Kamei Japan 20 720 0.6× 221 0.9× 65 0.4× 198 1.4× 57 0.4× 33 1.7k
Paul S. Jones United Kingdom 20 611 0.5× 230 0.9× 141 1.0× 112 0.8× 36 0.3× 44 1.2k
B. Therese Kinsella Ireland 26 1.5k 1.3× 118 0.5× 300 2.1× 235 1.6× 91 0.7× 79 2.4k
Xuejun Jiang China 19 654 0.5× 149 0.6× 183 1.3× 100 0.7× 40 0.3× 39 1.2k

Countries citing papers authored by Peter Canning

Since Specialization
Citations

This map shows the geographic impact of Peter Canning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Canning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Canning more than expected).

Fields of papers citing papers by Peter Canning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Canning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Canning. The network helps show where Peter Canning may publish in the future.

Co-authorship network of co-authors of Peter Canning

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Canning. A scholar is included among the top collaborators of Peter Canning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Canning. Peter Canning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stump, David A., et al.. (2022). “Comandante’’: Braving the Waves With Near Real-Time Virtual Production Workflows. 1–2. 1 indexed citations
2.
Canning, Peter, Carole J. R. Bataille, Nicolas Béry, et al.. (2021). Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds. Journal of Immunological Methods. 494. 113051–113051. 5 indexed citations
3.
Canning, Peter, Kristian Birchall, Catherine Kettleborough, Andy Merritt, & P.J. Coombs. (2020). Fragment-based target screening as an empirical approach to prioritising targets: a case study on antibacterials. Drug Discovery Today. 25(11). 2030–2037. 7 indexed citations
4.
Cruz-Migoni, Abimael, Peter Canning, Camilo Quevedo, et al.. (2019). Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds. Proceedings of the National Academy of Sciences. 116(7). 2545–2550. 101 indexed citations
5.
Salah, E., Deep Chatterjee, Anthony Tumber, et al.. (2019). Lessons from LIMK1 enzymology and their impact on inhibitor design. Biochemical Journal. 476(21). 3197–3209. 19 indexed citations
6.
Canning, Peter, Kwangjin Park, João Gonçalves, et al.. (2018). CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary Function. Cell Reports. 22(4). 885–894. 52 indexed citations
7.
Dinkova‐Kostova, Albena T., Rumen V. Kostov, & Peter Canning. (2016). Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants. Archives of Biochemistry and Biophysics. 617. 84–93. 263 indexed citations
8.
Canning, Peter, Tobias Schwerd, Matouš Hrdinka, et al.. (2015). Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors. Chemistry & Biology. 22(9). 1174–1184. 77 indexed citations
9.
Canning, Peter, F.J. Sorrell, & Alex N. Bullock. (2015). Structural basis of Keap1 interactions with Nrf2. Free Radical Biology and Medicine. 88(Pt B). 101–107. 475 indexed citations breakdown →
10.
Canning, Peter & Alex N. Bullock. (2014). New strategies to inhibit KEAP1 and the Cul3-based E3 ubiquitin ligases. Biochemical Society Transactions. 42(1). 103–107. 26 indexed citations
11.
Canning, Peter, Li Tan, Kiki Chu, et al.. (2014). Structural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase Inhibitors. Journal of Molecular Biology. 426(13). 2457–2470. 77 indexed citations
12.
Kim, Hyung-Gu, Li Tan, Ellen Weisberg, et al.. (2014). Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor. ACS Chemical Biology. 9(3). 840–840. 3 indexed citations
13.
Mohedas, Agustin H., You Wang, C. Sanvitale, et al.. (2014). Structure–Activity Relationship of 3,5-Diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. Journal of Medicinal Chemistry. 57(19). 7900–7915. 77 indexed citations
14.
Canning, Peter, Dean Rea, Rory E. Morty, & Vilmos Fülöp. (2013). Crystal Structures of Trypanosoma brucei Oligopeptidase B Broaden the Paradigm of Catalytic Regulation in Prolyl Oligopeptidase Family Enzymes. PLoS ONE. 8(11). e79349–e79349. 29 indexed citations
15.
Canning, Peter, C.D.O. Cooper, T. Krojer, et al.. (2013). Structural Basis for Cul3 Protein Assembly with the BTB-Kelch Family of E3 Ubiquitin Ligases. Journal of Biological Chemistry. 288(11). 7803–7814. 205 indexed citations
16.
Kim, Hyung-Gu, Li Tan, Ellen Weisberg, et al.. (2013). Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor. ACS Chemical Biology. 8(10). 2145–2150. 115 indexed citations
17.
Canning, Peter, C.D.O. Cooper, T. Krojer, et al.. (2013). Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.. Journal of Biological Chemistry. 288(39). 28304–28304. 6 indexed citations
18.
Canning, Peter, F. von Delft, & Alex N. Bullock. (2012). Structural Basis for ASPP2 Recognition by the Tumor Suppressor p73. Journal of Molecular Biology. 423(4). 515–527. 18 indexed citations
19.
Kaszuba, Karol, Tomasz Róg, Reinis Danne, et al.. (2012). Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidase. Biochimie. 94(6). 1398–1411. 49 indexed citations
20.
Kuźniar, Anna, et al.. (2001). Sustained In Vivo Activity of Recombinant Bovine Granulocyte Colony Stimulating Factor (rbG-CSF) Using HEPES Buffer. Pharmaceutical Development and Technology. 6(3). 441–447. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026